dsm-firmenich shares rise after Q2 earnings beat
BUZZ-dsm-firmenich shares rise after Q2 earnings beat ** Shares in dsm-firmenich DSFIR.AS rise 9% after the European chemicals maker reported Q2 results above market estimates
** The company's adjusted EBITDA came in at €466 million ($533 million), beating consensus of €452 million
** Jefferies says in a note all divisions beat its estimates, noting the double-digit growth in fine fragrance
** The group keeps its full-year organic sales growth (OSG) guidance of 2-4%, saying growth should come at the top end of the guidance
** J.P.Morgan says the strong acceleration in growth in June on easing Middle East tensions "might give bulls some fodder to argue that 2H OSG guidance may be conservative"
** But strong OSG growth may reflect temporary customer stockpiling, while full-year margin guidance implies a sharper improvement than seen in recent years, JPM adds
** The shares were up 9.14% at 0705 GMT, among the top movers on the STOXX 600 .STOXX index and on top of Amsterdam blue chips .AEX index
($1 = 0.8738 euros)
(Reporting by Vera Dvorakova)
Recent news on DSM-Firmenich AG
See all newsAnalysis: Brazil's corn ethanol boom accelerating growth of feedlot beef
Top of the Street: Hensoldt, Unilever, Evonik, dsm-firmenich, IMCD, AAK
Weak US sentiment hurts dietary supplement sales, offsetting broader growth, Novonesis CEO says
Europe Research Roundup: Asos, Erste Group, SCHOTT pharma
Dsm-firmenich raises growth outlook in line with expectations (updated)